NCT03955653

Brief Summary

The main objective of this proposed study is to examine if oblique projection (20- degrees right anterior oblique (RAO) for right femoral artery access or 20-degree left anterior oblique (LAO) for left femoral artery access) is superior to anterior projection (AP) for femoral artery access in zone 2-4 and thereby resulting in lower risk of access related complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 30, 2019

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

May 16, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 20, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2019

Completed
Last Updated

November 26, 2019

Status Verified

May 1, 2019

Enrollment Period

6 months

First QC Date

May 16, 2019

Last Update Submit

November 22, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • The percentage of access to the central portion of the femoral artery (Zone III)

    We will assess the access to the center of the femoral artery after insertion of the sheath for heart catheterization or PCI

    the procedure

  • The success rate of access to the Zone III

    We will define the access to the zone III with angiography

    the procedure

Secondary Outcomes (1)

  • The rate of access site complications

    the procedure

Study Arms (2)

RAO projection

ACTIVE COMPARATOR

Patients will be randomized to right anterior oblique (RAO) projection by fluoroscopy for the access to the femoral artery

Procedure: Femoral artey access

AP projection

ACTIVE COMPARATOR

Patients will be randomized to anterior-posterior projection by fluoroscopy for the access to the femoral artery

Procedure: Femoral artey access

Interventions

We will study the access to the femoral artery for cardiac catheterization or percutaneous coronary intervention

AP projectionRAO projection

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who are undergoing cardiac catheterization or PCI

You may not qualify if:

  • Peripheral vascular disease
  • Renal failure, Creatinine \>2.5 mg/dL
  • Hemodynamic instability, acute myocardial infarction
  • Heart failure with EF\<25%

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UAB

Birmingham, Alabama, 35294, United States

Location

Related Publications (1)

  • Leesar MA, Waheed S, Al Solaiman F, Chatterjee A, Daya HA, Hage FG, Brott BC. Randomized trial of an oblique versus standard fluoroscopic-guided micropuncture technique for femoral arterial access: The Micropuncture-CFA trial. Cardiovasc Revasc Med. 2023 Dec;57:43-50. doi: 10.1016/j.carrev.2023.06.029. Epub 2023 Jun 28.

Study Officials

  • Massoud A Leesar, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Patients will be randomized equally to the right anterior oblique view using fluoroscopy and the access to the femoral artery will be compared to that in the anterior-posterior projection
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

May 16, 2019

First Posted

May 20, 2019

Study Start

April 30, 2019

Primary Completion

October 30, 2019

Study Completion

October 30, 2019

Last Updated

November 26, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations